1. Home
  2. ATXG vs ACXP Comparison

ATXG vs ACXP Comparison

Compare ATXG & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ATXG

Addentax Group Corp.

N/A

Current Price

$4.80

Market Cap

4.1M

ML Signal

N/A

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

N/A

Current Price

$2.14

Market Cap

3.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ATXG
ACXP
Founded
2014
2017
Country
China
United States
Employees
112
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1M
3.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ATXG
ACXP
Price
$4.80
$2.14
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$95.50
AVG Volume (30 Days)
69.2K
159.1K
Earning Date
02-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.29
52 Week High
$7.94
$8.34

Technical Indicators

Market Signals
Indicator
ATXG
ACXP
Relative Strength Index (RSI) 51.31 42.54
Support Level $4.79 $1.89
Resistance Level $7.92 $2.89
Average True Range (ATR) 1.02 0.22
MACD -0.34 -0.02
Stochastic Oscillator 9.41 25.22

Price Performance

Historical Comparison
ATXG
ACXP

About ATXG Addentax Group Corp.

Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

Share on Social Networks: